225 related articles for article (PubMed ID: 22801295)
1. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
Eriksson TM; Holst S; Stan TL; Hager T; Sjögren B; Ogren SÖ; Svenningsson P; Stiedl O
Neuropharmacology; 2012 Nov; 63(6):1150-60. PubMed ID: 22801295
[TBL] [Abstract][Full Text] [Related]
2. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice.
Stiedl O; Misane I; Spiess J; Ogren SO
J Neurosci; 2000 Nov; 20(22):8515-27. PubMed ID: 11069959
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
6. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
[TBL] [Abstract][Full Text] [Related]
7. 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning.
Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
Hippocampus; 2009 Dec; 19(12):1187-98. PubMed ID: 19309036
[TBL] [Abstract][Full Text] [Related]
8. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA
FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
10. Cross state-dependency of learning between 5-HT1A and/or 5-HT7 receptor agonists and muscimol in the mouse dorsal hippocampus.
Jafari-Sabet M; Nemati S; Torab M
J Psychopharmacol; 2019 Jun; 33(6):722-736. PubMed ID: 30789290
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
[TBL] [Abstract][Full Text] [Related]
12. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
[TBL] [Abstract][Full Text] [Related]
13. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
Pejchal T; Foley MA; Kosofsky BE; Waeber C
Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
[TBL] [Abstract][Full Text] [Related]
14. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice.
Eriksson TM; Golkar A; Ekström JC; Svenningsson P; Ogren SO
Eur J Pharmacol; 2008 Oct; 596(1-3):107-10. PubMed ID: 18789922
[TBL] [Abstract][Full Text] [Related]
15. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
Shelton J; Bonaventure P; Li X; Yun S; Lovenberg T; Dugovic C
Neuropharmacology; 2009 Feb; 56(2):448-54. PubMed ID: 18948124
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
17. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
Guptarak J; Sarkar J; Hiegel C; Uphouse L
Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
[TBL] [Abstract][Full Text] [Related]
18. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
19. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice.
Pytka K; Gawlik K; Pawlica-Gosiewska D; Witalis J; Waszkielewicz A
Metab Brain Dis; 2017 Apr; 32(2):547-556. PubMed ID: 27888375
[TBL] [Abstract][Full Text] [Related]
20. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
